GEHC · NASDAQ
GE HealthCare Technologies (GEHC) Stock Price & Fundamentals
GE HealthCare Technologies (GEHC) closed at $461.44 on Oct 9, 2026, up 0.22% from the previous close of $460.44.
Share price, past year
1Y +13.95%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $461.44 |
| Sep 30, 2026 | $471.00 |
| Aug 31, 2026 | $461.38 |
| Jul 31, 2026 | $459.41 |
| Jun 30, 2026 | $444.95 |
| May 29, 2026 | $424.78 |
| Apr 30, 2026 | $404.38 |
| Mar 31, 2026 | $394.59 |
| Feb 27, 2026 | $402.25 |
| Jan 30, 2026 | $431.49 |
| Dec 31, 2025 | $430.09 |
| Nov 28, 2025 | $419.16 |
| Oct 31, 2025 | $424.12 |
Key statistics
- Market cap
- $210.30B
- P/E (TTM)
- 110.7
- EPS (TTM)
- $4.17
- Revenue (TTM)
- $20.98B
- Net income (TTM)
- $1.91B
- Shares outstanding
- 455.7M
- Dividend yield
- —
- 52-week range
- $379.75 – $482.82
GE HealthCare Technologies's market cap is $210.30B, based on a share price of $461.44 and 455.7M shares outstanding as of Jan 28, 2026.
Financials
GE HealthCare Technologies reported revenue of $20.63B for fiscal 2025, up 4.84% from fiscal 2024.
GE HealthCare Technologies earned net income of $2.08B in fiscal 2025, a net margin of 10.1%.
Fiscal 2025 revenue was the highest in the 5 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $20.63B | +4.8% | $2.08B | 10.1% | $4.55 | — |
| FY2024ended Dec 31, 2024 | $19.67B | +0.6% | $1.99B | 10.1% | $4.34 | — |
| FY2023ended Dec 31, 2023 | $19.55B | +6.6% | $1.57B | 8.0% | $3.03 | — |
| FY2022ended Dec 31, 2022 | $18.34B | +4.3% | $1.92B | 10.5% | $4.22 | — |
| FY2021ended Dec 31, 2021 | $17.59B | — | $2.25B | 12.8% | $4.95 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $5.13B | $389.00M | $0.85 |
| Q4 FY2025ended Dec 31, 2025 | $5.70B | $588.00M | $1.28 |
| Q3 FY2025ended Sep 30, 2025 | $5.14B | $446.00M | $0.98 |
| Q2 FY2025ended Jun 30, 2025 | $5.01B | $486.00M | $1.06 |
| Q1 FY2025ended Mar 31, 2025 | $4.78B | $564.00M | $1.23 |
| Q4 FY2024ended Dec 31, 2024 | $5.32B | $721.00M | $1.58 |
| Q3 FY2024ended Sep 30, 2024 | $4.86B | $470.00M | $1.02 |
| Q2 FY2024ended Jun 30, 2024 | $4.84B | $428.00M | $0.93 |
Company profile
- Name
- GE HealthCare Technologies Inc.
- Ticker
- GEHC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus
- Headquarters
- 500 West Monroe Street, Chicago, IL 60661
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001932393
Recent SEC filings
- Sep 22, 2026
- Aug 18, 2026
- Jul 29, 2026
- Jul 29, 2026
- Jul 29, 2026
- Jul 23, 2026
- May 11, 2026
- Apr 29, 2026
Frequently asked questions
What is GE HealthCare Technologies's stock price?
GE HealthCare Technologies (GEHC) closed at $461.44 on Oct 9, 2026, up 0.22% from the previous close of $460.44.
What is GE HealthCare Technologies's market cap?
GE HealthCare Technologies's market cap is $210.30B, based on a share price of $461.44 and 455.7M shares outstanding as of Jan 28, 2026.
How much revenue does GE HealthCare Technologies make?
GE HealthCare Technologies reported revenue of $20.63B for fiscal 2025, up 4.84% from fiscal 2024.
What is GEHC's P/E ratio?
GE HealthCare Technologies's price-to-earnings ratio is 110.7, based on trailing twelve-month diluted EPS of $4.17.
Does GE HealthCare Technologies pay a dividend?
Yes. GE HealthCare Technologies declared $0.14 per share in dividends for fiscal 2025.
Sources and methodology
Fundamentals come from GE HealthCare Technologies Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures